Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12287
Title: ASPECCT: panitumumab versus cetuximab for colorectal cancer.
Austin Authors: Hawkes, Eliza A ;Wong, Rachel
Affiliation: Department of Medical Oncology, Eastern Health, Box Hill, Victoria, Australia
Department of Oncology, Level 4, Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, PO Box 5555, Heidelberg, VIC 3084, Australia
Issue Date: 1-Jul-2014
Publication information: The Lancet. Oncology; 15(8): e302-3
Gov't Doc #: 24988927
URI: http://ahro.austin.org.au/austinjspui/handle/1/12287
DOI: 10.1016/S1470-2045(14)70269-4
URL: https://pubmed.ncbi.nlm.nih.gov/24988927
Type: Journal Article
Subjects: Antibodies, Monoclonal.therapeutic use
Antibodies, Monoclonal, Humanized.therapeutic use
Antineoplastic Agents.therapeutic use
Colorectal Neoplasms.drug therapy
Female
Humans
Male
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Dec 9, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.